Vetoquinol: Availability of the 2023 Universal Registration Document
April 24 2024 - 8:51AM
Business Wire
Regulatory News:
On 24 April 2024, Vetoquinol (Paris:VETO) filed its 2023
Universal Registration Document with the Autorité des Marchés
Financiers (AMF) in ESEF (European Single Electronic Format).
The 2023 Universal Registration Document in ESEF and PDF formats
(reproduction of the official version of the Universal Registration
Document in ESEF format) is available to the public under the
conditions provided by applicable regulations and may be consulted
on the “Investors” page of the Vetoquinol laboratory website
(www.vetoquinol.com), in the “Regulated Information” section. It is
also available on the AMF’s website (www.amf-france.org).
The 2023 Universal Registration Document includes:
- the 2023 Annual Financial Report;
- the Management Report;
- the Board of Directors Report on Corporate Governance;
- the Extra-Financial Performance Declaration;
- the information related to the fees paid to the Statutory
Auditors;
- the share buyback program description; and
- the agenda and draft resolutions of the Shareholder’s Meeting
of May 28th, 2024.
Next publication: sales 1st quarter 2024, April 29, 2024
after market close
ABOUT VETOQUINOL
Vetoquinol is a leading global animal health company that
supplies drugs and non-medicinal products for the farm animals
(cattle and pigs) and pet (dogs and cats) markets. As an
independent pure player, Vetoquinol designs, develops and sells
veterinary drugs and non-medicinal products in Europe, the Americas
and the Asia Pacific region. Since its foundation in 1933,
Vetoquinol has pursued a strategy combining innovation with
geographical diversification. The Group’s hybrid growth is driven
by the reinforcement of its product portfolio coupled with
acquisitions in high potential growth markets. At December 31,
2023, Vetoquinol employed 2,483 people.
Vetoquinol has been listed on Euronext Paris since 2006 (symbol:
VETO).
The Vetoquinol share is eligible for the French PEA and PEA-PME
personal equity plans.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240424734199/en/
FOR MORE INFORMATION, CONTACT:
VETOQUINOL
Investor Relations Fanny Toillon Tel.: +33 (0)3 84
62 59 88 relations.investisseurs@vetoquinol.com
Vetoquinol (EU:VETO)
Historical Stock Chart
From Oct 2024 to Nov 2024
Vetoquinol (EU:VETO)
Historical Stock Chart
From Nov 2023 to Nov 2024